Several other brokerages also recently issued reports on CBT. UBS Group reduced their price target on shares of Cabot from $86.00 to $83.00 and set a “buy” rating on the stock in a research report on Tuesday, November 7th. Credit Suisse Group dropped their price objective on Cabot from $85.00 to $82.00 and set an “outperform” rating for the company in a report on Tuesday, August 8th. Finally, JPMorgan Chase & Co. upped their price target on Cabot from $68.00 to $70.00 and gave the company a “neutral” rating in a research note on Friday, August 11th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $83.60.
Cabot Stock Up 2.6 %
Cabot (NYSE:CBT – Get Free Report) last issued its earnings results on Monday, November 6th. The specialty chemicals company reported $1.65 EPS for the quarter, beating the consensus estimate of $1.47 by $0.18. The company had revenue of $965.00 million for the quarter, compared to the consensus estimate of $991.48 million. Cabot had a net margin of 11.32% and a return on equity of 24.65%. The firm’s revenue for the quarter was down 13.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.55 EPS. Equities research analysts predict that Cabot will post 6.65 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Cabot
Institutional investors and hedge funds have recently bought and sold shares of the stock. Truist Financial Corp boosted its stake in Cabot by 5.3% in the 1st quarter. Truist Financial Corp now owns 6,734 shares of the specialty chemicals company’s stock worth $516,000 after purchasing an additional 336 shares during the period. Shelton Capital Management bought a new position in Cabot in the 1st quarter worth about $217,000. Fifth Third Bancorp boosted its stake in Cabot by 6.6% in the 2nd quarter. Fifth Third Bancorp now owns 23,067 shares of the specialty chemicals company’s stock worth $1,543,000 after purchasing an additional 1,437 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Cabot by 14.7% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,169 shares of the specialty chemicals company’s stock worth $703,000 after purchasing an additional 1,172 shares during the period. Finally, Wolverine Asset Management LLC bought a new position in Cabot in the 1st quarter worth about $536,000. 91.05% of the stock is owned by hedge funds and other institutional investors.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
- Five stocks we like better than Cabot
- Why Are Stock Sectors Important to Successful Investing?
- MarketBeat Week in Review – 11/6 – 11/10
- What Does the Consumer Price Index Measure?
- Data giants MongoDB and Snowflake just got upgraded
- Stock Market Sectors: What Are They and How Many Are There?
- Plug Power at tipping point; it’s make or break time for hydrogen
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.